Atchley v. Astrazeneca Uk Limited

CourtDistrict Court, District of Columbia
DecidedJuly 17, 2020
DocketCivil Action No. 2017-2136
StatusPublished

This text of Atchley v. Astrazeneca Uk Limited (Atchley v. Astrazeneca Uk Limited) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Atchley v. Astrazeneca Uk Limited, (D.D.C. 2020).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

JOSHUA ATCHLEY ef al., ) )

Plaintiffs, )

)

V. ) Civil Case No. 17-2136 (RJL)

ASTRAZENECA UK ) LIMITED, et al., ) )

Defendants. )

MEMORANDUM OPINION

Tl

July (7, 2020 [Dkt. ## 128, 130]

Plaintiffs in this suit are American service members, civilians, and their families who were murdered or wounded by terrorist attacks in Iraq between 2005 and 2011. They bring this suit against numerous pharmaceutical and medical equipment companies, some foreign and some domestic (collectively, “defendants”), alleging those companies knowingly financed the terrorist attacks that harmed them and are therefore liable under the Anti-Terrorism Act (“ATA”) and various state laws. All defendants move to dismiss, arguing that plaintiffs’ complaint fails to state a claim under the ATA.' See Defs.’ Mot. to

Dismiss (“Defs.’ Mot.) [Dkt. # 128]. The foreign defendants move to dismiss for lack of

' Defendants are: AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, GE Healthcare USA Holding LLC, GE Medical Systems Information Technologies, Inc., GE Medical Systems Information Technologies GmbH, Johnson & Johnson, Cilag GmbH International, Ethicon Endo- Surgery, LLC, Ethicon, Inc., Janssen Ortho LLC, Janssen Pharmaceutica N.V., Johnson & Johnson (Middle East) Inc., Ortho Biologics LLC, Pfizer Inc., Pfizer Enterprises SARL, Pfizer Pharmaceuticals LLC, Pharmacia & Upjohn Company LLC, Wyeth Pharmaceuticals Inc., F. Hoffman-La Roche Ltd., Genentech, Inc., and Hoffman-La Roche Inc. personal jurisdiction.” See Foreign Defs.’ Mot. to Dismiss for Lack of Personal Jurisdiction (“Defs.’ Juris. Mot.”) [Dkt. # 130].

While I deeply sympathize with plaintiffs for the losses they have endured, losses for which this country will be forever indebted, I cannot conclude that the law provides the relief plaintiffs seek in this case. Accordingly, and after due consideration of the briefing, oral argument, the relevant law, the entire record, and for the reasons stated below, foreign defendants’ Motion to Dismiss for lack of personal jurisdiction and defendants’ Motion to Dismiss for lack of subject-matter jurisdiction are GRANTED.

BACKGROUND

In March 2003, the United States and Coalition armed forces invaded Iraq and removed Saddam Hussein from power. See Third Am. Compl. (“TAC”) 4 54 [Dkt. # 124]. Following his removal, U.S., Coalition, and Iraqi military forces worked to rebuild Iraq while also engaged in years of armed conflict against various armed insurgent forces, including a group named Jaysh al-Mahdi (“JAM”). See id. J 54, 55, 59-61, 333; Defs.’ Mot. at 4. JAM functioned as the terrorist arm of the Iraqi Sadrists, a political group that was hostile to the United States. Id. 99] 56, 58-59. JAM was also supported by the terrorist group Hezbollah, which sought to undermine the United States’ efforts in Iraq and provided

JAM with training, supplies, and recruits. Id. [9 56, 62, 357.

* Foreign defendants are: AstraZeneca UK Limited, GE Medical Systems Information Technologies GmbH, Cilag GmbH International, Janssen Phamaceutica NV, Pfizer Enterprises SARL, and F. Hoffman-La Roche Ltd (collectively, “foreign defendants”). All defendants join the foreign defendants’ motion to dismiss for lack of jurisdiction as to plaintiffs’ state law claims.

2 Throughout Saddam’s regime and after, Iraq maintained a government-run healthcare system operated by the Iraqi Ministry of Health (“the Ministry” or “MOH”) and the Ministry’s state-owned import subsidiary, Kimadia. Jd. J§ 2, 72. The Ministry was a “sprawling bureaucracy” that employed “every public-sector doctor, pharmacist, nurse, and medical technician in Iraq.” Jd. 72. Kimadia was responsible for “importing and distributing” medical goods and had a monopoly over all medical imports in Iraq. Id. ¥] 72, 119.

Both the Ministry and Kimadia were openly plagued by corruption and profiteering. Id. 44 48, 129-30, 173. By late 2004, the Sadrists controlled the Ministry and Kimadia. Id. {{ 10, 63, 66, 68, 69, 70, 71, 73, 104. The Sadrists were linked to JAM, and some Ministry officials and employees were members of JAM. Jd. J§ 67, 69, 102, 165. According to plaintiffs, JAM used the Ministry to finance its terrorist activities and had “de facto control over the [Ministry’s] contracting process.” Jd. J§ 104-05. JAM capitalized on the Ministry’s “lack of any modern logistics system” and inability to “track[] the movement of goods and devices,” id. { 107, by “commandeering MOH facilities” and “looting MOH’s inventory for profits.” Id. § 3.

Beginning in 2004, defendants entered into supply agreements with the Ministry for the shipment of medical goods and equipment into Iraq. Jd. J 4-6, 128. Those contracts went through the Ministry’s procurement process, and they were negotiated and executed at “in-person meetings inside the Ministry’s headquarters building in Baghdad.” Jd. J§ 10, 119, 121. Among other things, the contracts’ terms generally reflected the country of origin

of the goods being sold. Jd. § 122. According to plaintiffs, suppliers would also

2 J “typically ... make the sale pursuant to an irrevocable letter of credit” in order to guarantee suppliers were paid for the goods. Jd. {§ 124, 127.

In addition to the medical goods contemplated by the contracts, defendants provided Ministry officials with in-kind drugs and equipment free of charge. Jd. 99 5, 116, 117. In fact, Kimadia’s standard bid instructions directed companies to provide extra goods for free as part of their agreements. Jd. § 120. Those goods “functioned as cash equivalents in Iraq” because they “possessed high street value” and “could be effectively monetized on regional black markets.” Jd. 4117. After the contracts were executed, defendants would ship both the contract goods and the free goods to a Kimadia warehouse in Iraq. Id. ¥ 128. After Kimadia transferred the inventory to Ministry warehouses, the goods were “often diverted” by Ministry employees to the black market. Jd. On top of the free goods, defendants also made cash payments to Ministry officials through “corrupt local agents.” Id. 99 6, 142, 145.

According to plaintiffs, defendants’ provision of free goods and cash payments to the Ministry financed JAM throughout the period between 2004 and 2013. See id. § 7, 13,167. The Sadrists controlled both the Ministry and Kimadia, which they used to supply JAM with “resources critical to its terrorist operations.” Jd. § 167. During that time, JAM carried out numerous terrorist attacks, capturing, torturing, and murdering Americans. See, e.g., id. [J 14, 333-46, 463, 787, 808. Some of those attacks killed or injured plaintiffs or

their relatives. Id. J§ 16, 62, 408-3180. LEGAL STANDARD

To survive a motion to dismiss for lack of personal jurisdiction under Federal Rule of Civil Procedure 12(b)(2), plaintiffs must “establish[] a factual basis for the exercise of personal jurisdiction over the defendant[s].” Crane v. New York Zoological Soc., 894 F.2d 454, 456 (D.C. Cir. 1990). Although “factual discrepancies appearing in the record must be resolved in favor of the plaintiff,” id., the Court “need not accept inferences drawn by plaintiffs if such inferences are unsupported by the facts,” Livnat v. Palestinian Auth., 851 F.3d 45, 57 (D.C. Cir. 2017) (internal quotation marks omitted). “Mere conclusions or ‘bare allegation[s]’ do not constitute the prima facie case for jurisdiction that this standard requires.” Fawzi v. Al Jazeera Media Network, 273 F. Supp. 3d 182, 186 (D.D.C. 2017) (quoting Livnat, 851 F.3d at 57).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Baker v. Carr
369 U.S. 186 (Supreme Court, 1962)
Schlesinger v. Reservists Committee to Stop the War
418 U.S. 208 (Supreme Court, 1974)
World-Wide Volkswagen Corp. v. Woodson
444 U.S. 286 (Supreme Court, 1980)
Keeton v. Hustler Magazine, Inc.
465 U.S. 770 (Supreme Court, 1984)
Calder v. Jones
465 U.S. 783 (Supreme Court, 1984)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
Japan Whaling Ass'n v. American Cetacean Society
478 U.S. 221 (Supreme Court, 1986)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
GTE New Media Services Inc. v. BellSouth Corp.
199 F.3d 1343 (D.C. Circuit, 2000)
Helmer, John v. Doletskaya, Elena
393 F.3d 201 (D.C. Circuit, 2004)
Mwani, Odilla Mutaka v. Bin Ladin, Usama
417 F.3d 1 (D.C. Circuit, 2005)
American Nat. Ins. Co. v. FDIC
642 F.3d 1137 (D.C. Circuit, 2011)
Halberstam v. Welch
705 F.2d 472 (D.C. Circuit, 1983)
Kent B. Crane v. New York Zoological Society
894 F.2d 454 (D.C. Circuit, 1990)
Zivotofsky Ex Rel. Zivotofsky v. Clinton
132 S. Ct. 1421 (Supreme Court, 2012)
Rothstein v. UBS AG
708 F.3d 82 (Second Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Atchley v. Astrazeneca Uk Limited, Counsel Stack Legal Research, https://law.counselstack.com/opinion/atchley-v-astrazeneca-uk-limited-dcd-2020.